Broken up by business lines, the company achieves 30 percent revenue growth for instruments and accessories; 23 percent revenue growth from systems and 23 percent revenue growth from services. Overall second quarter revenue growth was driven by continued adoption of da Vinci surgery procedures and higher da Vinci Surgical
System sales.
More Articles on Orthopedic Devices:
St. Jude Medical Recalls Pain Management Implant
Biomet Completes $1B Debt Offering
Mako Surgical Shareholders File Lawsuits Alleging Inflated Stock Prices
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
